Type I interferons promote the survival and proinflammatory properties of transitional B cells in systemic lupus erythematosus patients

Cell Mol Immunol. 2019 Apr;16(4):367-379. doi: 10.1038/s41423-018-0010-6. Epub 2018 Mar 21.

Abstract

A hallmark of systemic lupus erythematosus (SLE) is the breaking of B-cell tolerance with the generation of high-affinity autoantibodies; however, the antibody-independent features of the B-cell compartment in SLE are less understood. In this study, we performed an extensive examination of B-cell subsets and their proinflammatory properties in a Chinese cohort of new-onset SLE patients. We observed that SLE patients exhibited an increased frequency of transitional B cells compared with healthy donors and rheumatoid arthritis patients. Plasma from SLE patients potently promoted the survival of transitional B cells in a type I IFN-dependent manner, which can be recapitulated by direct IFN-α treatment. Furthermore, the effect of IFN-α on enhanced survival of transitional B cells was associated with NF-κB pathway activation and reduced expression of the pro-apoptotic molecule Bax. Transitional B cells from SLE patients harbored a higher capacity to produce proinflammatory cytokine IL-6, which was also linked to the overactivated type I IFN pathway. In addition, the frequency of IL-6-producing transitional B cells was positively correlated with disease activity in SLE patients, and these cells were significantly reduced after short-term standard therapies. Thus, the current study provides a direct link between type I IFN pathway overactivation and the abnormally high frequency and proinflammatory properties of transitional B cells in active SLE patients, which contributes to the understanding of the roles of type I IFNs and B cells in the pathogenesis of SLE.

Keywords: Systemic lupus erythematosus; apoptosis; interleukin 6; transitional B cells; type I interferons.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Apoptosis / drug effects
  • Apoptosis / immunology
  • Arthritis, Rheumatoid / blood
  • Arthritis, Rheumatoid / immunology
  • Autoantibodies / blood*
  • B-Lymphocyte Subsets / drug effects
  • B-Lymphocyte Subsets / immunology*
  • B-Lymphocyte Subsets / metabolism
  • Cell Survival / drug effects
  • Cell Survival / immunology
  • Cells, Cultured
  • China
  • Cohort Studies
  • Female
  • Humans
  • Inflammation / immunology
  • Inflammation / metabolism
  • Interferon-alpha / pharmacology*
  • Interleukin-6 / metabolism
  • Leukocytes, Mononuclear / metabolism
  • Lupus Erythematosus, Systemic / blood
  • Lupus Erythematosus, Systemic / immunology*
  • Lupus Erythematosus, Systemic / physiopathology
  • Lupus Erythematosus, Systemic / therapy
  • Male
  • Middle Aged
  • NF-kappa B / metabolism
  • Signal Transduction / drug effects
  • Signal Transduction / immunology
  • bcl-2-Associated X Protein / metabolism

Substances

  • Autoantibodies
  • BAX protein, human
  • Interferon-alpha
  • Interleukin-6
  • NF-kappa B
  • bcl-2-Associated X Protein